Funder: METAvivor
Due Dates: March 12, 2025 (Letter of Intent) | August 20, 2025 (Internal submission) | December 30, 2025 (Final submission)
Funding Amounts: Up to $200,000 total over two years (includes direct costs, up to $3,000 for travel, and up to 5% indirect costs)
Summary: Supports innovative research by early career investigators to advance treatment and outcomes for people living with metastatic breast cancer.